Silexion Therapeutics (SLXN) Operating Expenses (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Operating Expenses of $2.7 million for Q1 2026, up 66.61% year-over-year from $1.6 million in Q1 2025, and down 37.61% quarter-over-quarter from $4.4 million in Q4 2025.
Silexion Therapeutics (SLXN) Operating Expenses (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Operating Expenses history runs 4 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 66.61% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $12.7 million (down 1.85% YoY), while the FY2025 annual figure was $11.6 million, down 7.47% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.7 million, down from $4.4 million in the prior quarter.
- The five-year high for Operating Expenses was $8.0 million in Q3 2024, with the low at $731000.0 in Q3 2023.
- The 4-year median for Operating Expenses is $1.8 million (2023), against an average of $2.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 999.32% in 2024, then sank 59.03% in 2025.
- Silexion Therapeutics' Operating Expenses stood at $1.7 million in 2023, then rose by 9.95% to $1.9 million in 2024, then surged by 131.89% to $4.4 million in 2025, then plunged by 37.61% to $2.7 million in 2026.
- Business Quant data shows SLXN's Operating Expenses at $2.7 million in Q1 2026, $4.4 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | 3.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.68 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.41 Mn |